Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Hosted on MSN
AARD stock crashes 34% – here’s why this analyst finds it ‘hard to lean into’ Aardvark at this stage
・BTIG downgraded Aardvark Therapeutics to ‘Neutral’ from ‘Buy’ but did not provide a price target, according to The Fly. ・The firm said it is hard to bet on Aardvark given the uncertainties and the ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Capital Global Life Sciences Fund IV, L.P. Decheng, a 10% owner of $AARD, bought 625,000 shares of the company on 02-14-2025 for an estimated $10,000,000. This trade ...
SAN FRANCISCO, May 19, 2026 /PRNewswire/ -- On March 2, 2026, investors in Aardvark Therapeutics (NASDAQ: AARD) saw the price of their shares crater $7.02 (-56%) after the company announced that it ...
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...
Aardvark Therapeutics Inc. (NASDAQ: AARD) on Monday announced to voluntarily pause its Phase 3 HERO trial for Prader-Willi Syndrome. The update has sent the stock plunge almost 61%. The decision comes ...
Visit a quote page and your recently viewed tickers will be displayed here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results